Adverse drug reactions from two COVID-19 vaccines reported in Saudi Arabia.

Amjad F AlFaleh Abdullah AlkattanNashwa RadwanMona ElzohriAbrar AlzaherMona IbrahimEman AlsalameenAmani AlsultanDina AlhabibAlanood AlshelwahNagla MahmoudKhlood SagorKhaled Alabdulkareem

Published in: Drugs & therapy perspectives : for rational drug selection and use (2022)

There were significant differences regarding most of the reported ADRs and their onset among tozinameran and ChAdOx1 vaccines on both healthy people and high-risk individuals living in Saudi Arabia. Moreover, the study found that the frequencies of most listed ADRs were statistically different when seven batches of tozinameran vaccine were compared.

Keyphrases

adverse drug
coronavirus disease
sars cov
electronic health record
emergency department